These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13471142)

  • 21. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).
    Moxley RT; Logigian EL; Martens WB; Annis CL; Pandya S; Moxley RT; Barbieri CA; Dilek N; Wiegner AW; Thornton CA
    Muscle Nerve; 2007 Sep; 36(3):320-8. PubMed ID: 17587223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.
    Arsenault ME; Prévost C; Lescault A; Laberge C; Puymirat J; Mathieu J
    Neurology; 2006 Apr; 66(8):1248-50. PubMed ID: 16636244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Notes on prednisone therapy of Thomsen's myotonia and Steinert's myotonic dystrophy; clinical and biochemical study].
    SCARZELLA R
    G Psichiatr Neuropatol; 1957; 85(4):1001-14. PubMed ID: 13501611
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnosis and therapy of myotonic dystrophy in our practice of neuromuscular care].
    Merkli H; Pál E; Trauninger A; Kosztolányi P; Gáti I
    Orv Hetil; 2004 Mar; 145(10):523-8. PubMed ID: 15085591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myotonic dystrophy Curschmann-Steinert].
    Papageorgiou E; Bock SW; Schiefer U
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):70-5. PubMed ID: 17260325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpected resistance to pancuronium in a patient with myotonic dystrophy (myotonia dystrophica).
    Kodama K; Akata T; Sasaki T; Sakaguchi Y; Takahashi S
    J Anesth; 2000; 14(3):160-3. PubMed ID: 14564586
    [No Abstract]   [Full Text] [Related]  

  • 27. [Two cases of myotonia atrophica].
    KNIAZEVA GR; STOLIAROVA LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1959; 59(5):552-5. PubMed ID: 13676867
    [No Abstract]   [Full Text] [Related]  

  • 28. "Slow" myotonic discharges.
    Barkhaus PE; Nandedkar SD
    Muscle Nerve; 2006 Dec; 34(6):799-800. PubMed ID: 16927341
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychodynamics in a chronic debilitating hereditary disease. Myotonia dystrophica.
    Lynch HT; Tips RL; Krush A
    Arch Gen Psychiatry; 1966 Feb; 14(2):153-7. PubMed ID: 5901394
    [No Abstract]   [Full Text] [Related]  

  • 30. Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia.
    Milone M; Batish SD; Daube JR
    Muscle Nerve; 2009 Mar; 39(3):383-5. PubMed ID: 19208413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From gene to disease; altered RNA processing as a cause of myotonic dystrophy type 1].
    de Die-Smulders CE; Faber CG; Smeets HJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2043-6. PubMed ID: 16184945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.
    Kaliman P; Llagostera E
    Cell Signal; 2008 Nov; 20(11):1935-41. PubMed ID: 18583094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Encopresis revealing myotonic dystrophy in 2 children].
    Avez-Couturier J; Michaud L; Cuisset JM; Lamblin MD; Dolhem P; Turck D; Vallée L; Gottrand F
    Arch Pediatr; 2009 May; 16(5):430-4. PubMed ID: 19328663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heterogenecity of congenital myotonia].
    BECKER PE
    Nervenarzt; 1957 Oct; 28(10):455-60. PubMed ID: 13517431
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.
    Logigian EL; Blood CL; Dilek N; Martens WB; Moxley RT; Wiegner AW; Thornton CA; Moxley RT
    Muscle Nerve; 2005 Jul; 32(1):35-42. PubMed ID: 15880468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenic investigations on myasthenia and myotonia with special reference to therapy. II. Effect of blood serum isolated in myotonia on nerve-muscle preparation in frog].
    KURES H; MALEK P
    Cas Lek Cesk; 1952 Jun; 91(24-25):709-11. PubMed ID: 14390261
    [No Abstract]   [Full Text] [Related]  

  • 37. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative myotonia assessment using force relaxation curve modelling.
    Hogrel JY
    Physiol Meas; 2009 Jul; 30(7):719-27. PubMed ID: 19549998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shank sign in myotonic dystrophy type-1 (DM-1).
    Pradhan S
    J Clin Neurosci; 2007 Jan; 14(1):27-32. PubMed ID: 17092719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical picture of dystrophic myotonia].
    GUSEVA LL
    Klin Med (Mosk); 1958 Sep; 36(9):93-7. PubMed ID: 13599311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.